Fifty years of dopamine research

Trends in Neurosciences

Volumn 30, Issue 5, 2007, Pages 185-187

  Björklund, Anders ^a   Dunnett, Stephen B ^b  

^a LUND UNIVERSITY   (Sweden)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPA; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; LEVODOPA; NORADRENALIN; SEROTONIN; TYROSINE;

ATTENTION DEFICIT DISORDER; BRAIN REGION; EDITORIAL; NERVE CELL; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALS; BRAIN; DOPAMINE; HUMANS;

EID: 34247521096     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2007.03.004     Document Type: Editorial

References (24)

1. Carlsson A., et al. 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180 (1957) 1200
2. Carlsson A., et al. On the presence of 3-hydroxytyramine in brain. Science 127 (1958) 471
3. Montagu K.A. Catechol compounds in rat tissues and in brains of different animals. Nature 180 (1957) 244-245
4. Bertler A., and Rosengren E. Occurrence and distribution of dopamine in brain and other tissues. Experientia 15 (1959) 10-11
5. Sano I., et al. Distribution of catechol compounds in human brain. Biochim. Biophys. Acta 32 (1959) 586-587
6. Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11 (1959) 490-493
7. Hornykiewicz O. Dopamine miracle: from brain homogenate to dopamine replacement. Mov. Disord. 17 (2002) 501-508
8. Ehringer H., and Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des Extrapyramidalen Systems. Klin. Wochenschr. 38 (1960) 1236-1239
9. Birkmayer W., and Hornykiewicz O. Der l-Dioxyphenylalanin (l-Dopa)-Effekt bei der Parkinson-Akinese. Wien. Klin. Wochenschr. 73 (1961) 787-788
10. Barbeau A., et al. Les catecholamines de la maladie de Parkinson. In: de Ajuriaguerra J. (Ed). Monoamines et Système Nerveux Central (1962), Georg et Cie 247-267
11. Cotzias G.C., et al. Aromatic amino acids and modification of Parkinsonism. N. Engl. J. Med. 282 (1967) 31-33
12. Carlsson A. Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems. J. Neural Transm. 109 (2002) 777-787
13. Kebabian J.W., et al. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". Proc. Natl. Acad. Sci. U. S. A. 69 (1972) 2145-2149
14. Seeman P., et al. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976) 717-719
15. Iversen, L.L. and Iversen, S.D. Dopamine: 50 years in perspective. Trends Neurosci. doi:10.1016/j.tins.2007.03.002
16. Falck B., et al. Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10 (1962) 348-354
17. Dahlström A., and Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. 232 (1964) 1-55
18. Björklund, A. and Dunnett, S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci. in press
19. Schultz, W. Dopamine neurons and reward. Trends Neurosci. in press
20. Calabresi, P. et al. Dopaminergic regulation of corticostriatal plasticity. Trends Neurosci. doi:10.1016/j.tins.2007.03.001
21. Grace, A.A. et al. Dopamine neuron firing regulation of goal-directed behavior and motor habits. Trends Neurosci. doi:10.1016/j.tins.2007.03.003
22. Surmeier, D.J. Dopamine-glutamate interactions in the striatum. Trends Neurosci. in press
23. Cenci, M.A. Mechanisms of dyskinesia. Trends Neurosci. in press
24. Sulzer, D. Why do dopamine neurons die in Parkinson's disease. Trends Neurosci. in press